These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23166685)

  • 1. Protection against West Nile virus infection in mice after inoculation with type I interferon-inducing RNA transcripts.
    Rodríguez-Pulido M; Martín-Acebes MA; Escribano-Romero E; Blázquez AB; Sobrino F; Borrego B; Sáiz M; Saiz JC
    PLoS One; 2012; 7(11):e49494. PubMed ID: 23166685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. West Nile virus noncoding subgenomic RNA contributes to viral evasion of the type I interferon-mediated antiviral response.
    Schuessler A; Funk A; Lazear HM; Cooper DA; Torres S; Daffis S; Jha BK; Kumagai Y; Takeuchi O; Hertzog P; Silverman R; Akira S; Barton DJ; Diamond MS; Khromykh AA
    J Virol; 2012 May; 86(10):5708-18. PubMed ID: 22379089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. West Nile Virus-Inclusive Single-Cell RNA Sequencing Reveals Heterogeneity in the Type I Interferon Response within Single Cells.
    O'Neal JT; Upadhyay AA; Wolabaugh A; Patel NB; Bosinger SE; Suthar MS
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30626670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VAMP8 Contributes to the TRIM6-Mediated Type I Interferon Antiviral Response during West Nile Virus Infection.
    van Tol S; Atkins C; Bharaj P; Johnson KN; Hage A; Freiberg AN; Rajsbaum R
    J Virol; 2020 Jan; 94(2):. PubMed ID: 31694946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early production of type I interferon during West Nile virus infection: role for lymphoid tissues in IRF3-independent interferon production.
    Bourne N; Scholle F; Silva MC; Rossi SL; Dewsbury N; Judy B; De Aguiar JB; Leon MA; Estes DM; Fayzulin R; Mason PW
    J Virol; 2007 Sep; 81(17):9100-8. PubMed ID: 17567689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon regulatory factor IRF-7 induces the antiviral alpha interferon response and protects against lethal West Nile virus infection.
    Daffis S; Samuel MA; Suthar MS; Keller BC; Gale M; Diamond MS
    J Virol; 2008 Sep; 82(17):8465-75. PubMed ID: 18562536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Molecular Determinant of West Nile Virus Secretion and Morphology as a Target for Viral Attenuation.
    Basset J; Burlaud-Gaillard J; Feher M; Roingeard P; Rey FA; Pardigon N
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32269117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replication-Defective West Nile Virus with NS1 Deletion as a New Vaccine Platform for Flavivirus.
    Li N; Zhang YN; Deng CL; Shi PY; Yuan ZM; Zhang B
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31189715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity.
    Lai H; Paul AM; Sun H; He J; Yang M; Bai F; Chen Q
    Vaccine; 2018 Mar; 36(14):1846-1852. PubMed ID: 29490880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Interferon-Stimulated Gene Ifitm3 Restricts West Nile Virus Infection and Pathogenesis.
    Gorman MJ; Poddar S; Farzan M; Diamond MS
    J Virol; 2016 Sep; 90(18):8212-25. PubMed ID: 27384652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noncoding Subgenomic Flavivirus RNA Is Processed by the Mosquito RNA Interference Machinery and Determines West Nile Virus Transmission by Culex pipiens Mosquitoes.
    Göertz GP; Fros JJ; Miesen P; Vogels CBF; van der Bent ML; Geertsema C; Koenraadt CJM; van Rij RP; van Oers MM; Pijlman GP
    J Virol; 2016 Nov; 90(22):10145-10159. PubMed ID: 27581979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice.
    Liu WJ; Wang XJ; Clark DC; Lobigs M; Hall RA; Khromykh AA
    J Virol; 2006 Mar; 80(5):2396-404. PubMed ID: 16474146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The innate immune playbook for restricting West Nile virus infection.
    Quicke KM; Suthar MS
    Viruses; 2013 Oct; 5(11):2643-58. PubMed ID: 24178712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of inactivated West Nile vaccine (WN-VAX) in mice and monkeys.
    Muraki Y; Fujita T; Matsuura M; Fuke I; Manabe S; Ishikawa T; Okuno Y; Morita K
    Virol J; 2015 Apr; 12():54. PubMed ID: 25889682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice.
    Spohn G; Jennings GT; Martina BE; Keller I; Beck M; Pumpens P; Osterhaus AD; Bachmann MF
    Virol J; 2010 Jul; 7():146. PubMed ID: 20604940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization of flavivirus West Nile recombinant envelope domain III protein induced specific immune response and protection against West Nile virus infection.
    Chu JH; Chiang CC; Ng ML
    J Immunol; 2007 Mar; 178(5):2699-705. PubMed ID: 17312111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma interferon plays a crucial early antiviral role in protection against West Nile virus infection.
    Shrestha B; Wang T; Samuel MA; Whitby K; Craft J; Fikrig E; Diamond MS
    J Virol; 2006 Jun; 80(11):5338-48. PubMed ID: 16699014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relative contribution of antibody and CD8+ T cells to vaccine immunity against West Nile encephalitis virus.
    Shrestha B; Ng T; Chu HJ; Noll M; Diamond MS
    Vaccine; 2008 Apr; 26(16):2020-33. PubMed ID: 18339459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2'-O methylation of the viral mRNA cap by West Nile virus evades ifit1-dependent and -independent mechanisms of host restriction in vivo.
    Szretter KJ; Daniels BP; Cho H; Gainey MD; Yokoyama WM; Gale M; Virgin HW; Klein RS; Sen GC; Diamond MS
    PLoS Pathog; 2012; 8(5):e1002698. PubMed ID: 22589727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis.
    Desprès P; Combredet C; Frenkiel MP; Lorin C; Brahic M; Tangy F
    J Infect Dis; 2005 Jan; 191(2):207-14. PubMed ID: 15609230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.